500 related articles for article (PubMed ID: 18430829)
1. MRI techniques for prediction of local tumor progression after high-intensity focused ultrasonic ablation of prostate cancer.
Kim CK; Park BK; Lee HM; Kim SS; Kim E
AJR Am J Roentgenol; 2008 May; 190(5):1180-6. PubMed ID: 18430829
[TBL] [Abstract][Full Text] [Related]
2. Inter-reader agreement of multi-parametric MR imaging for the detection of prostate cancer: evaluation of a scoring system.
Quentin M; Arsov C; Röhlen S; Klasen J; Antoch G; Albers P; Blondin D
Rofo; 2012 Oct; 184(10):925-9. PubMed ID: 22744328
[TBL] [Abstract][Full Text] [Related]
3. Prostate cancer detection in patients with total serum prostate-specific antigen levels of 4-10 ng/mL: diagnostic efficacy of diffusion-weighted imaging, dynamic contrast-enhanced MRI, and T2-weighted imaging.
Tamada T; Sone T; Higashi H; Jo Y; Yamamoto A; Kanki A; Ito K
AJR Am J Roentgenol; 2011 Sep; 197(3):664-70. PubMed ID: 21862809
[TBL] [Abstract][Full Text] [Related]
4. Detection of prostate cancer with magnetic resonance imaging: optimization of T1-weighted, T2-weighted, dynamic-enhanced T1-weighted, diffusion-weighted imaging apparent diffusion coefficient mapping sequences and MR spectroscopy, correlated with biopsy and histopathological findings.
Aydin H; Kizilgöz V; Tatar IG; Damar C; Ugan AR; Paker I; Hekimoğlu B
J Comput Assist Tomogr; 2012; 36(1):30-45. PubMed ID: 22261768
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of prebiopsy multifunctional and morphologic MRI combined with free-to-total prostate-specific antigen ratio in the detection of prostate cancer.
Vilanova JC; Barceló-Vidal C; Comet J; Boada M; Barceló J; Ferrer J; Albanell J
AJR Am J Roentgenol; 2011 Jun; 196(6):W715-22. PubMed ID: 21606259
[TBL] [Abstract][Full Text] [Related]
6. Added value of breathhold diffusion-weighted MRI in detection of small hepatocellular carcinoma lesions compared with dynamic contrast-enhanced MRI alone using receiver operating characteristic curve analysis.
Xu PJ; Yan FH; Wang JH; Lin J; Ji Y
J Magn Reson Imaging; 2009 Feb; 29(2):341-9. PubMed ID: 19161186
[TBL] [Abstract][Full Text] [Related]
7. Locally recurrent prostate cancer after high-dose-rate brachytherapy: the value of diffusion-weighted imaging, dynamic contrast-enhanced MRI, and T2-weighted imaging in localizing tumors.
Tamada T; Sone T; Jo Y; Hiratsuka J; Higaki A; Higashi H; Ito K
AJR Am J Roentgenol; 2011 Aug; 197(2):408-14. PubMed ID: 21785087
[TBL] [Abstract][Full Text] [Related]
8. Prostate MR imaging at 3T using a phased-arrayed coil in predicting locally recurrent prostate cancer after radiation therapy: preliminary experience.
Kim CK; Park BK; Park W; Kim SS
Abdom Imaging; 2010 Apr; 35(2):246-52. PubMed ID: 19130116
[TBL] [Abstract][Full Text] [Related]
9. Peripheral zone prostate cancer localization by multiparametric magnetic resonance at 3 T: unbiased cancer identification by matching to histopathology.
Selnæs KM; Heerschap A; Jensen LR; Tessem MB; Schweder GJ; Goa PE; Viset T; Angelsen A; Gribbestad IS
Invest Radiol; 2012 Nov; 47(11):624-33. PubMed ID: 23011187
[TBL] [Abstract][Full Text] [Related]
10. Comparative sensitivities of functional MRI sequences in detection of local recurrence of prostate carcinoma after radical prostatectomy or external-beam radiotherapy.
Roy C; Foudi F; Charton J; Jung M; Lang H; Saussine C; Jacqmin D
AJR Am J Roentgenol; 2013 Apr; 200(4):W361-8. PubMed ID: 23521479
[TBL] [Abstract][Full Text] [Related]
11. Prostate cancer screening: the clinical value of diffusion-weighted imaging and dynamic MR imaging in combination with T2-weighted imaging.
Tanimoto A; Nakashima J; Kohno H; Shinmoto H; Kuribayashi S
J Magn Reson Imaging; 2007 Jan; 25(1):146-52. PubMed ID: 17139633
[TBL] [Abstract][Full Text] [Related]
12. Detection of Local Recurrence of Prostate Cancer After Radical Prostatectomy Using Endorectal Coil MRI at 3 T: Addition of DWI and Dynamic Contrast Enhancement to T2-Weighted MRI.
Kitajima K; Hartman RP; Froemming AT; Hagen CE; Takahashi N; Kawashima A
AJR Am J Roentgenol; 2015 Oct; 205(4):807-16. PubMed ID: 26397329
[TBL] [Abstract][Full Text] [Related]
13. Prediction of locally recurrent prostate cancer after radiation therapy: incremental value of 3T diffusion-weighted MRI.
Kim CK; Park BK; Lee HM
J Magn Reson Imaging; 2009 Feb; 29(2):391-7. PubMed ID: 19161194
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
Yoshizako T; Wada A; Hayashi T; Uchida K; Sumura M; Uchida N; Kitagaki H; Igawa M
Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
[TBL] [Abstract][Full Text] [Related]
15. Endorectal magnetic resonance imaging and magnetic resonance spectroscopy to monitor the prostate for residual disease or local cancer recurrence after transrectal high-intensity focused ultrasound.
Cirillo S; Petracchini M; D'Urso L; Dellamonica P; Illing R; Regge D; Muto G
BJU Int; 2008 Aug; 102(4):452-8. PubMed ID: 18476973
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of proton magnetic resonance spectroscopy in predicting positive biopsy after high-intensity focused ultrasound for treatment of localized prostate cancer.
Muto S; Kaminaga T; Horiuchi A; Kitamura K; Saito K; Isotani S; Yamaguchi R; Ide H; Furui S; Horie S
Int J Urol; 2014 Aug; 21(8):776-80. PubMed ID: 24650235
[TBL] [Abstract][Full Text] [Related]
17. Transition zone prostate cancer: revisiting the role of multiparametric MRI at 3 T.
Rosenkrantz AB; Kim S; Campbell N; Gaing B; Deng FM; Taneja SS
AJR Am J Roentgenol; 2015 Mar; 204(3):W266-72. PubMed ID: 25714311
[TBL] [Abstract][Full Text] [Related]
18. Diffusion-weighted MR imaging for the evaluation of seminal vesicle invasion in prostate cancer: initial results.
Kim CK; Choi D; Park BK; Kwon GY; Lim HK
J Magn Reson Imaging; 2008 Oct; 28(4):963-9. PubMed ID: 18821631
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic accuracy of biparametric vs multiparametric MRI in clinically significant prostate cancer: Comparison between readers with different experience.
Di Campli E; Delli Pizzi A; Seccia B; Cianci R; d'Annibale M; Colasante A; Cinalli S; Castellan P; Navarra R; Iantorno R; Gabrielli D; Buffone A; Caulo M; Basilico R
Eur J Radiol; 2018 Apr; 101():17-23. PubMed ID: 29571792
[TBL] [Abstract][Full Text] [Related]
20. Dynamic contrast-enhanced magnetic resonance imaging for localization of recurrent prostate cancer after external beam radiotherapy.
Haider MA; Chung P; Sweet J; Toi A; Jhaveri K; Ménard C; Warde P; Trachtenberg J; Lockwood G; Milosevic M
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):425-30. PubMed ID: 17881141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
